ConductScience.org, home

Paper39313896

Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review.

Upadhyay RK and 10 others. Curr Vasc Pharmacol, 2025. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review. Papers, record 39313896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39313896

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review.
PubMed
Journal
Curr Vasc Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-05-15
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Upadhyay RKRohit Kumar
2Kumar KKuldeep
3Vishwakarma VKVishal Kumar
4Singh NNirmal
5Narang RRajiv
6Parakh NNeeraj
7Yadav MMayank
8Yadav SSangeeta
9Kumar SSachin
10Goyal AAhsas
11Yadav HNHarlokesh Narayan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NADPH OxidasesMajor topic
Cardiovascular DiseasesMajor topic
Oxidative StressMajor topic
Cardiovascular AgentsMajor topic
Cardiovascular SystemMajor topic
Enzyme InhibitorsMajor topic
AntioxidantsMajor topic
Humans
Animals
Reactive Oxygen Species
Signal Transduction
Molecular Targeted Therapy

Source PubMed

Download CSV of topics

References214

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136009488Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease.Biomedicines2022https://conductscience.org/library/papers/36009488PubMed
231487802Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?Nutrients2019https://conductscience.org/library/papers/31487802PubMed
328626501NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells.Oxid Med Cell Longev2017https://conductscience.org/library/papers/28626501PubMed
422530599Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.Antioxid Redox Signal2013https://conductscience.org/library/papers/22530599PubMed
517237347The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.Physiol Rev2007https://conductscience.org/library/papers/17237347PubMed
615039755NOX enzymes and the biology of reactive oxygen.Nat Rev Immunol2004https://conductscience.org/library/papers/15039755PubMed
722747566NADPH oxidases in heart failure: poachers or gamekeepers?Antioxid Redox Signal2013https://conductscience.org/library/papers/22747566PubMed
818769233Differential vascular functions of Nox family NADPH oxidases.Curr Opin Lipidol2008https://conductscience.org/library/papers/18769233PubMed
919438290Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases.Antioxid Redox Signal2009https://conductscience.org/library/papers/19438290PubMed
1023991888Reactive oxygen species in inflammation and tissue injury.Antioxid Redox Signal2014https://conductscience.org/library/papers/23991888PubMed
1112855411Vascular NAD(P)H oxidases: specific features, expression, and regulation.Am J Physiol Regul Integr Comp Physiol2003https://conductscience.org/library/papers/12855411PubMed
1214588154Role of NADPH oxidases in the control of vascular gene expression.Antioxid Redox Signal2003https://conductscience.org/library/papers/14588154PubMed
1316987004NOX2 and NOX4 mediate proliferative response in endothelial cells.Antioxid Redox Signal2006https://conductscience.org/library/papers/16987004PubMed
1410485709Cell transformation by the superoxide-generating oxidase Mox1.Nature1999https://conductscience.org/library/papers/10485709PubMed
159405639Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9405639PubMed
1611483596A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes.J Biol Chem2001https://conductscience.org/library/papers/11483596PubMed
1716771662NADPH oxidases in cardiovascular health and disease.Antioxid Redox Signal2006https://conductscience.org/library/papers/16771662PubMed
1813654378The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.J Biol Chem1959https://conductscience.org/library/papers/13654378PubMed
194379032Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells.Experientia1964https://conductscience.org/library/papers/4379032PubMed
2014213063CHANGES IN THE METABOLIC PATTERN OF POLYMORPHO-NUCLEAR LEUCOCYTES DURING PHAGOCYTOSIS.Br J Exp Pathol1964https://conductscience.org/library/papers/14213063PubMed

See all 214 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42812766Targeting vascular inflammation and endothelial dysfunction with nanobodies: emerging therapeutic strategies for cardiovascular disease.Front Immunol2026https://conductscience.org/library/papers/42812766PubMed
41596076Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease.Antioxidants (Basel)2025https://conductscience.org/library/papers/41596076PubMed
41389127Crosstalk between Ryanodine Receptor 2 Dysfunction and FK506-Binding Proteins in Pulmonary Hypertension.Cardiovasc Drugs Ther2026https://conductscience.org/library/papers/41389127PubMed
41045403Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis.Mol Cell Biochem2026https://conductscience.org/library/papers/41045403PubMed
40327837Impact of Hematopoietic CD14 on Oxidative Stress during Salt-Sensitive Hypertension and Kidney Injury.J Am Soc Nephrol2025https://conductscience.org/library/papers/40327837PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DECR11666PubTator's text mininghttps://conductscience.org/library/genes/1666

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39313896

GET https://conductscience.org/api/papers/v1/39313896/references?page=2